BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16817941)

  • 1. Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register.
    Symmons DP; Silman AJ
    Arthritis Res Ther; 2006; 8(4):214. PubMed ID: 16817941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity.
    van der Helm-van Mil AH; Breedveld FC; Huizinga TW
    Arthritis Res Ther; 2006; 8(4):216. PubMed ID: 16879719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register.
    Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Marshall T; Lunt M; Verstappen SMM
    Arthritis Rheumatol; 2017 Aug; 69(8):1566-1575. PubMed ID: 28425173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.
    Cook MJ; Diffin J; Scirè CA; Lunt M; MacGregor AJ; Symmons DP; Verstappen SM
    Rheumatology (Oxford); 2016 Sep; 55(9):1601-9. PubMed ID: 27220594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register.
    Farragher TM; Lunt M; Bunn DK; Silman AJ; Symmons DP
    Ann Rheum Dis; 2007 Apr; 66(4):486-92. PubMed ID: 17090565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register.
    Plant D; Thomson W; Lunt M; Flynn E; Martin P; Eyre S; Farragher T; Bunn D; Worthington J; Symmons D; Barton A
    Rheumatology (Oxford); 2011 Jan; 50(1):78-84. PubMed ID: 20219786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.
    Michaud K; Berglind N; Franzén S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Nyberg F; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Askling J
    Ann Rheum Dis; 2016 Oct; 75(10):1797-805. PubMed ID: 26857699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
    Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
    J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has the severity of rheumatoid arthritis at presentation diminished over time?
    Diffin JG; Lunt M; Marshall T; Chipping JR; Symmons DP; Verstappen SM
    J Rheumatol; 2014 Aug; 41(8):1590-9. PubMed ID: 24986850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register.
    Humphreys JH; Verstappen SM; Hyrich KL; Chipping JR; Marshall T; Symmons DP
    Ann Rheum Dis; 2013 Aug; 72(8):1315-20. PubMed ID: 22945499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Norfolk Arthritis Register (NOAR).
    Symmons DP; Silman AJ
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S94-9. PubMed ID: 14969058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study.
    Barrett EM; Scott DG; Wiles NJ; Symmons DP
    Rheumatology (Oxford); 2000 Dec; 39(12):1403-9. PubMed ID: 11136885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
    Castrejón I; Dougados M; Combe B; Fautrel B; Guillemin F; Pincus T
    J Rheumatol; 2016 Jul; 43(7):1285-91. PubMed ID: 27084913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR).
    Mirjafari H; Welsh P; Verstappen SM; Wilson P; Marshall T; Edlin H; Bunn D; Chipping J; Lunt M; Symmons DP; Sattar N; Bruce IN
    Ann Rheum Dis; 2014 Apr; 73(4):684-90. PubMed ID: 23511225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association.
    Harrison BJ; Symmons DP; Barrett EM; Silman AJ
    J Rheumatol; 1998 Dec; 25(12):2324-30. PubMed ID: 9858425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants associated with work participation in patients with established rheumatoid arthritis taking tumor necrosis factor inhibitors.
    Manders SH; Kievit W; Braakman-Jansen AL; Brus HL; Hendriks L; Fransen J; van de Laar MA; van Riel PL
    J Rheumatol; 2014 Jul; 41(7):1263-9. PubMed ID: 24833758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register.
    Verstappen SM; Watson KD; Lunt M; McGrother K; Symmons DP; Hyrich KL;
    Rheumatology (Oxford); 2010 Aug; 49(8):1570-7. PubMed ID: 20444856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register.
    Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Marshall T; Lunt M; Verstappen SMM
    Ann Rheum Dis; 2018 Jun; 77(6):848-854. PubMed ID: 29475855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.